SCHEMBL14877166

SCHEMBL14877166

O=c1nc(-c2c[nH]c3ccccc23)[nH]c2ccc(N3CCCCC3)cc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 6/20 0.47
▸ PDGFRB P09619 4/20 0.43
▸ FGFR1 P11362 4/20 0.42
▸ FGFR2 P21802 1/20 0.42
▸ AR P10275 1/20 0.41
▸ JAK1 P23458 3/20 0.41
▸ JAK3 P52333 3/20 0.41
▸ KDR P35968 3/20 0.41
▸ JAK2 O60674 2/20 0.41
▸ PRKCB P05771 2/20 0.41
▸ PRKCA P17252 2/20 0.41
▸ PRKCH P24723 2/20 0.41
▸ PRKCE Q02156 2/20 0.41
▸ PRKCQ Q04759 2/20 0.41
▸ PRKCD Q05655 2/20 0.41
▸ IP6K1 Q92551 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ TYK2 P29597 1/20 0.40
▸ FLT1 P17948 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14877015 0.99 KIF11 (0.46) KIF11PDGFRBFGFR1FGFR2AR
SCHEMBL14877399 0.89 PDGFRB (0.56) KIF11PDGFRBFGFR1JAK1JAK3
SCHEMBL14877438 0.84 KIF11 (0.49) KIF11PDGFRBFGFR1ARKDR
SCHEMBL14877168 0.84 KDM4E (0.53) KIF11PDGFRBFGFR1FGFR2KDR
SCHEMBL14877134 0.83 KIF11 (0.47) KIF11PDGFRBFGFR1ARKDR
SCHEMBL14877017 0.83 KDM4E (0.53) KIF11PDGFRBFGFR1FGFR2KDR
SCHEMBL15389029 0.81 KIF11 (0.46) KIF11PDGFRBFGFR1ARKDR
SCHEMBL14876948 0.80 KIF11 (0.44) KIF11PDGFRBFGFR1ARKDR
SCHEMBL14876999 0.75 ABCG2 (0.53) PDGFRBFGFR1FGFR2KDRPRKCB
SCHEMBL14876863 0.75 JAK2 (0.47) PDGFRBFGFR1FGFR2ARJAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9045437-B2 2-aryl-4-quinazolinones and their pharmaceutical compositions CHINA MEDICAL UNIVERSITY (TW) 2015-06-02 — — US disclosed
US-9006239-B2 2-aryl-4-quinazolinones and their pharmaceutical compositions CHINA MEDICAL UNIVERSITY (TW) 2015-04-14 — — US disclosed
US-8710064-B2 2-aryl-4-quinazolinones and their pharmaceutical compositions CHINA MEDICAL UNIVERSITY (TW) 2014-04-29 — — US disclosed
US-20140018363-A1 2-ARYL-4-QUINAZOLINONES AND THEIR PHARMACEUTICAL COMPOSITIONS CHINA MEDICAL UNIVERSITY (TW) 2014-01-16 — — US disclosed
US-20130310376-A1 2-ARYL-4-QUINAZOLINONES AND THEIR PHARMACEUTICAL COMPOSITIONS CHINA MEDICAL UNIVERSITY (TW) 2013-11-21 — — US disclosed
US-20130102602-A1 2-Aryl-4-Quinazolinones And Their Pharmaceutical Compositions CHINA MEDICAL UNIVERSITY (TW) 2013-04-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130102602-A1 2-Aryl-4-Quinazolinones And Their Pharmaceutical Compositions AQP4, KRAS, RB1 KIF11 1929/4885PDGFRB 1297/4885FGFR1 620/4885
US-20130310376-A1 2-ARYL-4-QUINAZOLINONES AND THEIR PHARMACEUTICAL COMPOSITIONS CCNE2, NFE2, NR2E1 KIF11 2269/4885PDGFRB 1708/4885FGFR1 2322/4885
US-20140018363-A1 2-ARYL-4-QUINAZOLINONES AND THEIR PHARMACEUTICAL COMPOSITIONS CCNE2, RB1, NR2E1 KIF11 2111/4885PDGFRB 1731/4885FGFR1 1767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback